Literature DB >> 9282166

Spatial-temporal patterns of gene expression in mouse skeletal muscle after injection of lacZ plasmid DNA.

S G Doh1, H L Vahlsing, J Hartikka, X Liang, M Manthorpe.   

Abstract

Gene therapy for muscular diseases requires the efficient transfection of a large proportion of myofiber cells within a given muscle. In the present experiments, patterns of beta-galactosidase expression were examined in mouse rectus femoris muscles at various time-points after a single injection of lacZ encoded plasmid DNA. beta-Galactosidase expression was detected 3 h after injection and rose to peak levels at 3-14 days, and then stabilized at lower levels. beta-Galactosidase staining was detected in an average of about 6% (up to 15%) of the total 4000 myofiber cells, and in about 70% of those myofibers located in the discrete area containing the greatest proportion of transfected cells. Soon after injection of DNA encoding cytoplasmic or nuclear-targeted beta-galactosidase, expression was noted predominantly in the myotendinous junction areas, after which beta-galactosidase activity progressed toward the central parts of the myofibers. This preferential transgene expression at the myotendinous junction may result from some unique, local property of the myofiber cells and/or from a restricted diffusion or binding of the injected plasmid DNA at tendinous surfaces. A better understanding of the reasons for this pattern of reporter gene expression in muscle may suggest procedures for increasing the number of myofiber cells transfected by direct DNA injections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9282166     DOI: 10.1038/sj.gt.3300460

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  17 in total

1.  The safety and longevity of DNA vaccines for fish.

Authors:  T Kanellos; I D Sylvester; A G Ambali; C R Howard; P H Russell
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

2.  Synergy between cationic lipid and co-lipid determines the macroscopic structure and transfection activity of lipoplexes.

Authors:  Marilyn E Ferrari; Denis Rusalov; Joel Enas; Carl J Wheeler
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

Review 3.  Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals.

Authors:  David A Dean
Journal:  Am J Physiol Cell Physiol       Date:  2005-08       Impact factor: 4.249

Review 4.  Intracellular trafficking of plasmids for gene therapy: mechanisms of cytoplasmic movement and nuclear import.

Authors:  Erin E Vaughan; James V DeGiulio; David A Dean
Journal:  Curr Gene Ther       Date:  2006-12       Impact factor: 4.391

5.  Intramuscular delivery of DNA releasing microspheres: microsphere properties and transgene expression.

Authors:  Jae-Hyung Jang; Lonnie D Shea
Journal:  J Control Release       Date:  2006-03-10       Impact factor: 9.776

6.  Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects.

Authors:  Mary K Wloch; Larry R Smith; Souphaphone Boutsaboualoy; Luane Reyes; Christina Han; Jackie Kehler; Heather D Smith; Linda Selk; Ryotaro Nakamura; Janice M Brown; Thomas Marbury; Anna Wald; Alain Rolland; David Kaslow; Thomas Evans; Michael Boeckh
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 5.226

7.  Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation.

Authors:  G Rizzuto; M Cappelletti; D Maione; R Savino; D Lazzaro; P Costa; I Mathiesen; R Cortese; G Ciliberto; R Laufer; N La Monica; E Fattori
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

8.  A model for testing the immunogenicity of simian immunodeficiency virus and simian-human immunodeficiency virus vaccine candidates in mice.

Authors:  Jun Xu; Matthew Kelly; Warren Denning; Zdenek Hel
Journal:  J Virol Methods       Date:  2009-01-30       Impact factor: 2.014

9.  Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment.

Authors:  Anna-Karin Roos; Fredrik Eriksson; James A Timmons; Josefine Gerhardt; Ulrika Nyman; Lindvi Gudmundsdotter; Andreas Bråve; Britta Wahren; Pavel Pisa
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

10.  A detailed characterisation of the distribution and presentation of DNA vaccine encoded antigen.

Authors:  Catherine M Rush; Timothy J Mitchell; Paul Garside
Journal:  Vaccine       Date:  2009-12-23       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.